COVID-PCD is a participatory study initiated by people with primary ciliary dyskinesia (PCD)
who have an essential vote in all stages of the research from the design of the study to the …

Introduction Primary ciliary dyskinesia (PCD) is a rare, genetic, multiorgan disease with an
estimated prevalence of 1 in 10 000. It affects mainly the upper and lower airways due to …

The need for collaborative research networks as an effective way forward to improve
diagnosis and care of rare inherited diseases is constantly highlighted and primary ciliary …

Background Primary ciliary dyskinesia (PCD) is a rare genetic disorder characterised by
pulmonary, otological and sino-nasal manifestations. Well-defined clinical outcome measures …

Background Mostly derived from chart reviews, where symptoms are recorded in a nonstandardised
manner, clinical data about primary ciliary dyskinesia (PCD) are inconsistent, which …

Importance Otologic disease is common among people with primary ciliary dyskinesia (PCD),
yet little is known about its spectrum and severity. Objective To characterize otologic …

Primary ciliary dyskinesia (PCD) is a rare genetic disease that causes recurrent respiratory
infections. People with PCD may be at higher risk of severe coronavirus disease 2019 (…

Background Sinonasal symptoms are a common feature of primary ciliary dyskinesia (PCD);
however, literature about their severity and frequency, particularly during the life course, is …

Introduction Nearly all patients with primary ciliary dyskinesia (PCD) report ear–nose–throat
(ENT) symptoms. However, scarce evidence exists about how ENT symptoms relate to …

Background: Despite advances in primary ciliary dyskinesia (PCD) research, many questions
remain; diagnosis is complex and no disease specific therapies exist. Using a mixed-…